Skip to content

Effect of Xuefu Zhuyu Capsule on chest pain after thoracoscopic surgery for early non-small cell lung cancer

Effect of Xuefu Zhuyu Capsule on chest pain after thoracoscopic surgery for early non-small cell lung cancer

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100051270
Enrollment
Unknown
Registered
2021-09-17
Start date
2021-09-20
Completion date
Unknown
Last updated
2022-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

NSCLC

Interventions

Sponsors

Peking University People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patients who underwent thoracoscopic sublobar, lobar, compound lobe or pneumonectomy with or without mediastinal lymph node resection; 2. Postoperative pathological diagnosis of primary non-small cell lung cancer stage I, IIA or carcinoma in situ; 3. No chest pain before surgery and chest pain within 3 months after surgery; 4. Aged 18 to 85 years; 5. Voluntarily participate in clinical trials, sign informed consent, and be able to contact follow-up; 6. Only those who meet all the above conditions can be included in the study.

Exclusion criteria

Exclusion criteria: 1. Combined with serious primary diseases of the heart, brain, kidney and other serious diseases; 2. Mental patients; 3. Those who meet the diagnostic criteria for non-small cell lung cancer but have undergone surgery, radiotherapy, chemotherapy, targeted therapy and received traditional Chinese medicine within the past 3 months.

Design outcomes

Primary

MeasureTime frame
Effective rate of pain improvement;Cough score;Quality of life score;TCM syndrome integral;

Countries

China

Contacts

Public ContactMeng Yufeng

Peking University People's Hospital

1173809106@qq.com+86 18810901822

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026